rs1483573

▶

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

lymphocyte count

Sakaue S et al. “A cross-population atlas of genetic associations for 220 human phenotypes.” Nature Genetics 53(10):1415-1424 (2021)
Allele G
OR 0.04
p 7.0e-60
N 445,573
Large GWAS
multi-ancestry

neutrophil percentage of leukocytes

Vuckovic D et al. “The Polygenic and Monogenic Basis of Blood Traits and Diseases.” Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.03
p 5.0e-39
N 408,112
Large GWAS
European
Loya H et al. “A scalable variational inference approach for increased mixed-model association power.” Nature Genetics 57(2):461-468 (2025)
Allele G
OR 0.03
p 3.0e-30
N 394,642
Large GWAS
European

integrin beta-7 measurement

Loya H et al. “A scalable variational inference approach for increased mixed-model association power.” Nature Genetics 57(2):461-468 (2025)
Allele G
OR 0.04
p 6.0e-16
N 47,745
Large GWAS
European
▶

Research that mentions this SNP (1)

▶
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility
AssociationN=7,792Rebecca L. Zuvich et al.(2010)· Human Genetics

This pathway-based association study identified genetic variations in the IL7RA/IL7 signaling pathway that increase multiple sclerosis susceptibility. Two novel genes replicated in an independent dataset: IL7 (rs2587156, p=8.29×10−6, OR=1.35) and SOCS1 (rs441349, p=3.48×10−7, OR=1.25). Additional candidate genes with suggestive evidence include PRKCE (p=3.47×10−4), BCL2 (p=4.32×10−4), and TYK2. The study analyzed 2,961 MS cases and controls in discovery, with 4,831 samples in replication, examining 7,865 SNPs across 73 genes in this biologically-relevant immune pathway.

Traits studied:Multiple sclerosis
PubMedDOIMetascience Observatory

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…